Hepatitis A virus (HAV) is naturally transmitted by the fecal-oral route but can also be transmitted intravenously. To determine the relative infectivity of these 2 routes, an infectivity titration of a standard challenge pool of virulent HAV was performed in tamarins and chimpanzees. In both species, 1 oral dose of HAV was equivalent to 10 4.5 intravenous doses. These findings have relevance for attempts to develop live, attenuated HAV vaccines that can be administered orally.
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Hepatitis A virus (HAV), a pathogen that is transmitted by the fecal-oral route, continues to have significant impact on human health worldwide. Effective inactivated hepatitis A vaccines have been licensed, but an orally administered, live, attenuated vaccine would be more practical for use in developing countries. Attempts to develop such vaccines have not been successful, however, and the only licensed (in China) live, attenuated hepatitis A vaccine must be administered by injection [1] . This and other candidate live, attenuated hepatitis A vaccines have required parenteral administration because of difficulties in achieving consistent infection by the oral route with the titers of virus available from cell culture.
The purpose of the present study was to characterize further the biology of HAV infection by determining the relative infectivity of a wild-type HAV strain when administered by the oral versus the intravenous (iv) route. The relationship between the infectious dose of virus and markers of infection was also studied.
Materials and Methods
Animals. This study was performed with tamarins (Saguinus mystax) and chimpanzees (Pan troglodytes) because previous studies demonstrated comparable sensitivity of these 2 species to iv infection with HAV [2] . Eighteen wild-caught tamarins and 10 domestically raised chimpanzees were housed at Bioqual (Rockville, MD). Blood samples were obtained weekly, and serum was tested for the following liver enzyme activities: alanine aminotransferase (ALT), isocitrate dehydrogenase (ICD), and gamma glutamyl transferase levels.
The tests were performed with commercial reagents at Metpath (Rockville, MD). Although the results obtained for the 3 enzymes paralleled each other in both species, tamarins were evaluated with the ICD test and chimpanzees were evaluated with the ALT test because of greater respective sensitivity. To minimize the number of animals used, chimpanzees and tamarins that were not infected with 1 dose of HAV were reinoculated with a larger dose and reevaluated.
Challenge virus. The SD-11 strain of HAV was recovered from a naval recruit, 1 of 136 persons who contracted hepatitis A from a cook who prepared salads and desserts in a navy galley during the prodromal period of his HAV infection [3] . A 2% suspension of acute-phase feces from this patient was prepared in veal infusion broth supplemented with 0.5% bovine serum albumin, filtered through a 1.2-mm filter (Millipore), aliquoted, and stored at 280 C until administration to the animals. The inoculum was free of other viruses, as determined by inoculation of primary African green monkey kidney cells [4] and by electron microscopy (authors' unpublished data).
Serologic tests. Serum samples from experimentally inoculated tamarins and chimpanzees were tested for antibody to HAV with the Havab test (Abbott Laboratories).
Analysis. Infection was scored by detection of seroconversion. Infectivity titers were calculated by standard methods [5] .
Results
Tamarins and chimpanzees were inoculated iv or orally (via gastric tube) with 0.5 mL of 10-fold dilutions of a standard filtrate of human feces containing the SD-11 strain of HAV (table 1). All animals were followed for at least 15 weeks. Two tamarins were inoculated with each dilution that was tested for infectivity, and end points of infectivity were bracketed. All tamarins that received iv inoculations of feces at dilutions as great as 10 28 and 1 of 2 animals that received dilutions of 10 29 were infected, whereas dilutions only as great as 10 24 were infectious when administered by the oral route (table 1) . Thus, the infectivity titers of the pool were 10 9.0 and 10 4.5 when administered to tamarins by the iv and oral routes, respectively. A somewhat less extensive infectivity titration of the pool in chimpanzees confirmed that the infectivity titers were 10 9 and 10 4.5 when administered by the iv and oral routes, respectively (table 1). Thus, 10 4.5 -fold more virus was required to infect by the oral route than by the iv route.
As shown in table 1 and figure 1A and 1B, there was an inverse relationship between the infectious dose of HAV administered and the incubation period of the resultant hepatitis, as measured by the interval to peak liver enzyme activity (i.e., ICD level) and to seroconversion, respectively, in tamarins. In contrast, there was no relationship between the infectious dose of virus administered and the maximum liver enzyme activity observed (table 1 and figure 1C ). Thus, we did not detect a relationship between infectious dose and clinical response. Similar results were observed in chimpanzees (table 1).
Discussion
The finding that wild-type HAV was 10 4.5 -fold less infectious by the oral, compared with the iv, route of infection was somewhat surprising, since HAV is normally transmitted via the fecaloral route. Our data probably reflect a true difference in infectivity titer, since the incubation period and other clinical characteristics of infection were the same for a single infectious dose, whether measured by titration via the oral or the iv route.
This study was prompted, in part, by similar studies of wildtype and partially attenuated pools of the HM-175 strain of HAV in chimpanzees [2, 7] (and authors' unpublished data) and of a highly attenuated pool of this virus in volunteers [8] . In the former studies, both wild-type and partially attenuated viruses were at least 10 4 times less infectious by the oral route than when administered iv. In the latter study, tissue culture-adapted HAV, 
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---NOTE. The suspension used was for evaluation of morbidity and viral shedding following oral challenge of tamarins in a separate preclinical trial of HAV vaccine [6] . Dashes (-) indicate uninfected animals.
a Isocitrate dehydrogenase levels (Sigma units) were measured in tamarins, and alanine aminotransferase levels (U/mL) were measured in chimpanzees.
strain HM-175, was administered orally or intramuscularly (im) to young adult volunteers. Doses as large as 10 7 TCID 50 failed to infect the volunteers by the oral route, whereas 10 6 and 10 7 TCID 50 but not 10 5 TCID 50 of the same virus administered im resulted in seroconversions (without hepatitis or virus recovery) in the volunteers. Although the anti-HAV response in these volunteers resembled that seen after infection, it may have been only a response to the antigenic mass of 10 6 -10 7 hepatitis A viruses. Thus, this highly attenuated HAV may have been at least 10 2 -fold less infectious by the oral route than by the im route. Since HAV seldom grows to titers .10 8 TCID 50 in cell culture, the poor infectivity of HAV by the oral route is a practical limitation to the development of orally administered live, attenuated HAV vaccines, and even administration of such vaccines by parenteral (im or subcutaneous) routes has required high titers of virus to achieve uniform responses in recipients [1, 8, 9] .
It is unclear how far one can extrapolate these data to other picornaviruses. During his development of oral polio vaccines, Albert Sabin demonstrated that chimpanzees were somewhat less sensitive than humans to oral infection with the attenuated polio virus strains and that macaque monkeys were less sensitive than chimpanzees to such infection [10, 11] . Sabin also demonstrated that volunteers were more susceptible to infection with the attenuated polio viruses when they were administered by the oral route than when administered by the im route [10] , in contrast to our results with attenuated HAV [8] . This result may reflect the greater capacity for polio viruses to replicate in the intestinal tract than for HAV to do so. Indeed, a bona fide site of replication of HAV in the intestinal tract has not been unequivocally identified, and most of the HAV found in the intestinal tract is believed to have reached the intestine from the liver via the bile [12] [13] [14] [15] .
In summary, an intestinal barrier to infection with HAV appears to exist, at least in 2 disparate species of nonhuman primates and probably in humans, and this provides an impediment to the development of an inexpensive and effective orally administered hepatitis A vaccine. Since the currently available inactivated hepatitis A vaccines are too expensive for developing countries, an economical and effective vaccine for those at highest risk of infection remains a goal for the future. 
